Entero Healthcare Solutions Ltd. (ENTERO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has a cash flow conversion efficiency ratio of -0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-572.73 Million ≈ $-6.19 Million USD) by net assets (Rs17.97 Billion ≈ $194.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Entero Healthcare Solutions Ltd. (ENTERO) net asset quality to measure how much of total assets are equity-financed.
Entero Healthcare Solutions Ltd. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Entero Healthcare Solutions Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ENTERO cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Entero Healthcare Solutions Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TOMTOM N.V.ADRS 1/2 EO-20
F:OEMB
|
0.065x |
|
Guangdong Jinma Entertainment Corp Ltd
SHE:300756
|
0.009x |
|
Energiekontor AG
F:EKT
|
-0.007x |
|
Interfor Corp
TO:IFP
|
-0.011x |
|
Woori Technology Inc
KQ:032820
|
-0.028x |
|
Kvika banki hf
IC:KVIKA
|
0.046x |
|
Mattr Corp
TO:MATR
|
0.106x |
|
Italtile Ltd
JSE:ITE
|
0.137x |
Annual Cash Flow Conversion Efficiency for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Entero Healthcare Solutions Ltd. from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see ENTERO company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Rs17.53 Billion ≈ $189.53 Million |
Rs693.22 Million ≈ $7.50 Million |
0.040x | +187.18% |
| 2024-09-30 | Rs17.70 Billion ≈ $191.46 Million |
Rs-803.24 Million ≈ $-8.69 Million |
-0.045x | -103.41% |
| 2023-09-30 | Rs16.41 Billion ≈ $177.51 Million |
Rs-366.12 Million ≈ $-3.96 Million |
-0.022x | +69.10% |
| 2022-09-30 | Rs6.28 Billion ≈ $67.89 Million |
Rs-453.15 Million ≈ $-4.90 Million |
-0.072x | -15.29% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.91 Million |
Rs-352.66 Million ≈ $-3.81 Million |
-0.063x | +55.60% |
| 2020-09-30 | Rs4.87 Billion ≈ $52.67 Million |
Rs-686.84 Million ≈ $-7.43 Million |
-0.141x | -63.81% |
| 2019-09-30 | Rs4.24 Billion ≈ $45.88 Million |
Rs-365.19 Million ≈ $-3.95 Million |
-0.086x | -- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more